« Previous
Next »
The American Journal of Surgery
Volume 193, Issue 3
, Pages 331-335
, March 2007
Raf-1 activation in gastrointestinal carcinoid cells decreases tumor cell adhesion
References
- Isolated liver metastases from neuroendocrine tumors: does resection prolong survival?. J Am Coll Surg. 1998;187:88–93
- Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients. J Am Coll Surg. 1998;187:487–493
- Gastrointestinal carcinoid tumors: factors that predict outcome. World J Surg. 2004;28:387–392
- . Treatment of advanced carcinoid tumors. Curr Opin Oncol. 2006;18:9–15
- A mouse model of carcinoid syndrome and heart disease. J Surg Res. 2005;126:102–105
- Differentiation of medullary thyroid cancer by C-raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1. Surgery. 1996;120:168–173
- Raf-1 activation suppresses neuroendocrine marker and hormone levels in human gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol. 2003;285:G245–G254
- . Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1. Thyroid. 2005;15:511–521
- . The raf-1 pathway: a molecular target for treatment of select neuroendocrine tumors?. Anticancer Drugs. 2006;17:139–142
- Regulation of neuroendocrine differentiation in gastrointestinal carcinoid tumor cells by notch signaling. J Clin Endocrinol Metab. 2005;90:4350–4356
- Hairy enhancer of split-1 (HES-1), a Notch1 effector, inhibits the growth of carcinoid tumor cells. Surgery. 2005;138:1137–1142
- . Conservation of the Notch1 signaling pathway in gastrointestinal carcinoid cells. Am J Physiol Gastrointest Liver Physiol. 2005;289:G636–G642
- . Activation of the ras/raf-1 signal transduction pathway in carcinoid tumor cells results in morphologic transdifferentiation. Surgery. 2002;132:1035–1039
- Mutations of critical amino acids affect the biologic and biochemical properties of oncogenic A-raf and raf-1. Oncogene. 1997;15:1021–1033
- Raf-induced proliferation or cell cycle arrest is determined by the level of raf activity with arrest mediated by p21Cip1. Mol Cell Biol. 1997;17:5598–5611
- Irby RB, Yeatman TJ. Increased src activity disrupts cadherin/catenin-mediated homotypic adhesion in human colon cancer and transformed rodent cells. Cancer Res 200;62:2669–74.
- ZM336372, a raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells. Mol Cancer Ther. 2005;4:910–917
- The role of human achaete-scute homolog-1 in medullary thyroid cancer cells. Surgery. 2003;134:866–873
- Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion. J Cell Biol. 1989;108:2435–2447
- Mutations of the human E-cadherin (CDH1) gene. Hum Mutat. 1998;12:226–237
- A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature. 1998;392:190–193
- . Wnt signaling and cancer. Genes Dev. 2000;14:1837–1851
- . Linking colorectal cancer to wnt signaling. Cell. 2000;103:311–332
- Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 1996;382:638–642
- ZM336372, a raf-1 activator, inhibits growth of pheochromocytoma cells. J Surg Res. 2006;133:42–45
PII: S0002-9610(06)00794-X
doi: 10.1016/j.amjsurg.2006.09.016
© 2007 Excerpta Medica Inc. All rights reserved.
« Previous
Next »
The American Journal of Surgery
Volume 193, Issue 3
, Pages 331-335
, March 2007
